HMC selects 2005 board of directors

The Healthcare Marketing & Communications Council (HMC Council) has announced its board of directors for 2005.
Kenneth Berkowitz, president of KPB Associates and co-principal of PharMed Staffing, was named president of the 2005 board. Martin Cearnal will serve as president-elect. Cearnal is the chief strategy officer at Thomson Medical Education. Marie Mickey, principal of The Avery Group, was named secretary. Melissa Warner, group vice president and general manager of CMP Healthcare Media's Oncology Publishing Group, will be the treasurer.
Also, Mary Lacquaniti was recently selected as executive director after an exhaustive recruitment effort.
A major initiative, which is currently being planned, is the first annual HMC University Development Conference slated for October 20 and 21 to be held in Princeton, N.J.

In addition to the officers named above, HMC's board of directors for 2005 includes:
Robin Bartlett, director of sales and business development, American College of Physicians;
Andrea Bevacqua, director/team leader, Pfizer's Helpful Answers program;
Mark Boulding, senior vice president, business development and legal, PTC Therapeutics;
Janet Carlson, founder and president, One Eleven Interactive;
Janis Cohen, president and chief executive, Global Edge, immediate HMC Council past president;
Robert Doyle, vice president, marketing operations, Novartis Pharmaceuticals;
Peter Frishauf, founder of Medscape and SCP Communications, past president HMC Council 2002 and 2003;
Carol Jaxel, vice president, education development, Ethecol Institute;
Kenneth Jones, executive vice president and general manager, Compas and CMI;
Nancy Kohler, director, advertising operations and commercial operations sourcing, Sanofi-Aventis;
Nancy Larsen, president, PROmedica Communications, HMC Council past president 1999;
Maureen Dwyer Liberti, senior account manager, Monthly Prescribing Reference, a division of Haymarket Media;
Harry Sweeney, chief executive, Dorland Global Health Communications, HMC Council past president 2001;
Chris Tompson, executive director, healthcare compliance, Johnson & Johnson Worldwide.

You must be a registered member of MMM to post a comment.

Email Newsletters

What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.

A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.